Vigabatrin
Product Images NDC 70377-089

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 70377-089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

The packaging label for Vigabatrin for Oral Solution, USP by Biocon Pharma Inc. shows the product as 500 mg per packet in a pack of 50 packets. The label includes directions for use, manufacturer and distributor information, NDC 70377-089-01, and a barcode. The design features white background with blue and yellow accents, and the Biocon logo.*

FDA Label Image

Chemical Structure (Chemstructure)

Chemical structure of vigabatrin, an active pharmaceutical ingredient. The diagram shows atoms and bonds representing the molecular framework, including an amino group and a carboxylic acid functionality consistent with vigabatrin's known chemical composition.*

FDA Label Image

Figure1 (Figure1)

A line graph titled 'Percent Reduction from Baseline in Seizure Frequency' showing percentage reduction in seizure frequency on the y-axis against percentage of patients on the x-axis. Four lines represent placebo, 1g/day VGB, 3g/day VGB, and 6g/day VGB, illustrating comparative seizure frequency reductions with increasing VGB dosage. Directional arrows indicate improvement upwards and worsening downwards.*

FDA Label Image

Figure2 (Figure2)

A cumulative frequency plot showing percentage reduction in seizure frequency in patients treated with Vigabatrin (3g/day VGB) compared to placebo. The x-axis represents percentage of patients, and the y-axis shows percentage reduction in seizure frequency, with labels indicating improvement above zero and worsening below. The graph features two lines, one for placebo and one for Vigabatrin, illustrating treatment effects on seizure frequency.*

FDA Label Image

Figure3 (Figure3)

Vigabatrin for Oral Solution, USP 500 mg single-use packet with dosing syringes shown alongside a glass with a spoon and another glass of water. The product is associated with NDC 72158-101 and is labeled for pharmacy dispensing. The labeler shown in the product data is Biocon Pharma Inc.*

FDA Label Image

Figure4 (Figure4)

A labeled diagram of an oral syringe showing parts labeled as Tip, Dosage Indicators, Bottom of the white plunger, Barrel, and Plunger. The syringe barrel displays graduation marks from 1 mL up to 10 mL used for measuring liquid volume.*

FDA Label Image

Figurea (Figurea)

Illustration labeled 'Figure A' showing a hand pouring a powder from a packet into a transparent empty glass. The packet text is partially visible but mostly unreadable. The image appears to demonstrate the action of dissolving or mixing powder in a glass.*

FDA Label Image

Figureb (Figureb)

Photograph showing two clear square drinking glasses side by side on a white surface. The left glass contains a small amount of clear liquid, while the right glass is mostly empty with few clear residues at the bottom. Caption below the image reads 'Figure B'.*

FDA Label Image

Figurec (Figurec)

An instructional illustration showing a hand holding a 10 mL syringe-like measuring device partially submerged into a clear liquid in a square glass cup. The syringe is marked with graduated volume measurements from 1 mL to 10 mL, and the image likely demonstrates how to measure liquid medication volume accurately.*

FDA Label Image

Figured (Figured)

Photograph showing a hand holding a plastic oral dosing syringe marked in milliliters from 1 mL to 10 mL. The syringe is filled with liquid at approximately 4.5 mL. The background is a plain textured wall. The image appears instructional rather than packaging or labeling.*

FDA Label Image

Figuree (Figuree)

A close-up photograph shows a hand holding a clear 10 mL syringe. The syringe barrel is marked with black measurement lines for volumes from 1 mL to 10 mL. A black arrow with text points to the 10 mL line on the syringe. The background is a plain textured white wall. The image is labeled "Figure E" beneath.*

FDA Label Image

Figuref (Figuref)

An instructional image showing a hand holding a marked syringe above a clear glass containing powder at the bottom. The syringe has volume markings from 1 mL to 10 mL, suggesting a measurement or preparation step involving liquids and the powder in the glass.*

FDA Label Image

Figureg (Figureg)

An illustration shows a hand holding a metal spoon stirring a clear liquid in a transparent glass. The image is labeled as 'Figure G' at the bottom.*

FDA Label Image

Figureh (Figureh)

An illustration showing a hand holding a white oral syringe marked with volume graduations from 1 mL to 10 mL, partially submerged in a clear liquid in a square glass container. The image appears to demonstrate liquid measurement or dispensing.*

FDA Label Image

Figurei (Figurei)

Illustration shows a hand holding an oral dosing syringe marked from 1 mL to 10 mL, designed for accurate measurement and administration of liquid medication. The syringe is filled to about the 2 mL mark. This image is likely intended to demonstrate measurement or administration technique for VIGABATRIN oral solution by Biocon Pharma Inc.*

FDA Label Image

Figurej (Figurej)

Illustration showing a young child receiving medication orally from a dosing syringe held by an adult hand. The child is positioned with the syringe tip at the lips to facilitate administration of liquid medicine. This image suggests the method of dosing liquid medication to a pediatric patient.*

FDA Label Image

Packet (Packet)

Label for Vigabatrin for Oral Solution, USP 500 mg in a single packet. The front side displays the product name, dosage strength, NDC 70377-089-01, and Biocon logo. The back side includes directions for use, storage instructions, manufacturer and labeler information (WES Pharma Inc. and Biocon Pharma Inc.), and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.